Mark L. Berch

Array ( [id] => 6967211 [patent_doc_number] => 20050234108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => '8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/060703 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13779 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20050234108.pdf [firstpage_image] =>[orig_patent_app_number] => 11060703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5254000 [patent_doc_number] => 20070135456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Medicaments with hm74a receptor activity' [patent_app_type] => utility [patent_app_number] => 10/589474 [patent_app_country] => US [patent_app_date] => 2005-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23733 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135456.pdf [firstpage_image] =>[orig_patent_app_number] => 10589474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5673157 [patent_doc_number] => 20060178512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Method for preparing amino acid esters of nucleoside analogues' [patent_app_type] => utility [patent_app_number] => 11/051895 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8066 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178512.pdf [firstpage_image] =>[orig_patent_app_number] => 11051895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632308 [patent_doc_number] => 20060148778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Regioselective hydroxylation, functionalisation and protection of spirolactams II' [patent_app_type] => utility [patent_app_number] => 11/047860 [patent_app_country] => US [patent_app_date] => 2005-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9511 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148778.pdf [firstpage_image] =>[orig_patent_app_number] => 11047860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667827 [patent_doc_number] => 20060173177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Process for preparation of penam derivatives' [patent_app_type] => utility [patent_app_number] => 11/046080 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6023 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20060173177.pdf [firstpage_image] =>[orig_patent_app_number] => 11046080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051342 [patent_doc_number] => 20050187229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Crystalline forms of valacyclovir hydrochloride' [patent_app_type] => utility [patent_app_number] => 11/042526 [patent_app_country] => US [patent_app_date] => 2005-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11224 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187229.pdf [firstpage_image] =>[orig_patent_app_number] => 11042526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7098534 [patent_doc_number] => 20050130993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Synthesis and purification of valacyclovir' [patent_app_type] => utility [patent_app_number] => 11/042538 [patent_app_country] => US [patent_app_date] => 2005-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5769 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130993.pdf [firstpage_image] =>[orig_patent_app_number] => 11042538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7188314 [patent_doc_number] => 20050192296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Process for the preparation of valacyclovir hydrochloride' [patent_app_type] => utility [patent_app_number] => 11/040925 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4179 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192296.pdf [firstpage_image] =>[orig_patent_app_number] => 11040925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952215 [patent_doc_number] => 20050227309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Optically-detectable enzyme substrates and their method of use' [patent_app_type] => utility [patent_app_number] => 11/040924 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 51952 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227309.pdf [firstpage_image] =>[orig_patent_app_number] => 11040924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7188314 [patent_doc_number] => 20050192296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Process for the preparation of valacyclovir hydrochloride' [patent_app_type] => utility [patent_app_number] => 11/040925 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4179 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192296.pdf [firstpage_image] =>[orig_patent_app_number] => 11040925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 250886 [patent_doc_number] => 07582642 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Purine derivatives' [patent_app_type] => utility [patent_app_number] => 11/033692 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23957 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582642.pdf [firstpage_image] =>[orig_patent_app_number] => 11033692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281825 [patent_doc_number] => 07553825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Anti-proliferative compounds, compositions, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/026303 [patent_app_country] => US [patent_app_date] => 2004-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34388 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553825.pdf [firstpage_image] =>[orig_patent_app_number] => 11026303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005767 [patent_doc_number] => 20050171080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Polymorphs of ezetimibe and process for preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/022570 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 3466 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171080.pdf [firstpage_image] =>[orig_patent_app_number] => 11022570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070499 [patent_doc_number] => 20070191601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Process for production of intermediates for use in cefalosporin synthesis' [patent_app_type] => utility [patent_app_number] => 10/583159 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3379 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191601.pdf [firstpage_image] =>[orig_patent_app_number] => 10583159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615150 [patent_doc_number] => 20100099657 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2010-04-22 [patent_title] => 'Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity' [patent_app_type] => utility [patent_app_number] => 10/596731 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63794 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0099/20100099657.pdf [firstpage_image] =>[orig_patent_app_number] => 10596731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120589 [patent_doc_number] => 20070142304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Diphenylazetidinone derivatives possessing chloesterol absorption inhibitory activity' [patent_app_type] => utility [patent_app_number] => 10/596725 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21526 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142304.pdf [firstpage_image] =>[orig_patent_app_number] => 10596725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615150 [patent_doc_number] => 20100099657 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2010-04-22 [patent_title] => 'Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity' [patent_app_type] => utility [patent_app_number] => 10/596731 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63794 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0099/20100099657.pdf [firstpage_image] =>[orig_patent_app_number] => 10596731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840440 [patent_doc_number] => 20080280926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Phosphodiesterase Inhibitors' [patent_app_type] => utility [patent_app_number] => 10/596528 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9607 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280926.pdf [firstpage_image] =>[orig_patent_app_number] => 10596528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 880557 [patent_doc_number] => 07355043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Preparation of purines' [patent_app_type] => utility [patent_app_number] => 11/011352 [patent_app_country] => US [patent_app_date] => 2004-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1355 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/355/07355043.pdf [firstpage_image] =>[orig_patent_app_number] => 11011352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 923129 [patent_doc_number] => 07319101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'COMT inhibitors for the treatment of depression and impaired cognition' [patent_app_type] => utility [patent_app_number] => 11/011887 [patent_app_country] => US [patent_app_date] => 2004-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34120 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319101.pdf [firstpage_image] =>[orig_patent_app_number] => 11011887 [rel_patent_id] =>[rel_patent_doc_number] =>)